Repurposing Dopamine Agonist Pramipexole for Disabling AnhedoniaByKenneth J. Bender, PharmD, MASeptember 3rd 2026
When Treatment-Resistant Depression Means Mismatched: Rethinking Difficult-to-Treat DepressionByWalter Paganin, MD, PhDAugust 31st 2026
Novel Serotonergic Agonist, HLP003, Targets the Adjunctive MDD Treatment GapByKen Kramer, PhDAugust 30th 2026
Debunking HRT Myths: Why Hormone Therapy Should Be Standard of Care in PsychiatryByNardin Valentin, DOAugust 29th 2026